Yi-Cian Zheng to Cell Line, Tumor
This is a "connection" page, showing publications Yi-Cian Zheng has written about Cell Line, Tumor.
Connection Strength
0.066
-
The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma. Mol Cancer. 2024 02 22; 23(1):40.
Score: 0.034
-
Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment. Oncotarget. 2023 05 26; 14:543-560.
Score: 0.032